US Food and Drug Administration approves artificial pancreas system

CamAPS FX. Credit: CamDiab An artificial pancreas developed by researchers at the University of Cambridge has been granted approval by the U.S. Food and Drug Administration (FDA) for use by individuals with type 1 diabetes aged 2 and older, including during pregnancy. This means that even more people living with the disease will be able to use this life-changing app. For the first time, the FDA authorized the use of the artificial pancreas system in pregnancy. CamAPS FX, produced by Cambridge spinout company CamDiab, is an Android app that can Read More